Cyanobacteria are among the most ancient organisms on Earth and have evolved chemical weapons for defensive purposes, which we are exploiting for anticancer drug discovery. Our past research has exemplified that marine cyanobacteria produce compounds with exceptionally potent activity and/or possess unusual or first- in-class inhibitors with novel mechanisms of action. We apply a broad yet focused screening platform to maximize discovery rate of new anticancer agents. We also integrate a synthetic chemistry component into our program in order to perform rigorous biological studies to rapidly add value to our discoveries and to help solve the supply problem. Specifically, we will carry out field collections of marine cyanobacteria and prepare fraction libraries for screening in a set of innovative pathway-focused cell-based assays, utilizing various isogenic colorectal cancer cell lines and reporter gene assays, as well as newly developed unbiased phenotypic assays. We will perform dereplication, identify cyanobacteria through molecular analysis and establish phylogenetic relationships among benthic cyanobacteria. Samples will be prioritized based on bioactivity profiles and genetic uniqueness for further processing. Prioritized samples will be subjected to bioassay-guided isolation of the active compounds. Structures will be determined using NMR and mass spectrometry. Basic validation of bioactivity and secondary assays will be performed before prioritizing targets for further investigation. Selected compounds with intriguing structure and promising validated bioactivity will be targeted for total synthesis so that a rigorous biological characterization can be performed to pinpoint the molecular changes induced in the cancer cell and to determine potential direct targets. For novel noncytotoxic compounds that show potential antimetastatic activity, we will apply an orthogonal target-based screening platform.

Public Health Relevance

Marine cyanobacteria produce selective anticancer agents with specific molecular targets. This research will lead to the discovery of new compounds that could become new drug leads for the treatment of cancer.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
2R01CA172310-06
Application #
9658207
Study Section
Synthetic and Biological Chemistry B Study Section (SBCB)
Program Officer
Fu, Yali
Project Start
2013-03-06
Project End
2024-08-31
Budget Start
2019-09-01
Budget End
2020-08-31
Support Year
6
Fiscal Year
2019
Total Cost
Indirect Cost
Name
University of Florida
Department
Pharmacology
Type
Schools of Pharmacy
DUNS #
969663814
City
Gainesville
State
FL
Country
United States
Zip Code
32611
Cai, Weijing; Ratnayake, Ranjala; Gerber, Michael H et al. (2018) Development of apratoxin S10 (Apra S10) as an anti-pancreatic cancer agent and its preliminary evaluation in an orthotopic patient-derived xenograft (PDX) model. Invest New Drugs :
Cai, Weijing; Salvador-Reyes, Lilibeth A; Zhang, Wei et al. (2018) Apratyramide, a Marine-Derived Peptidic Stimulator of VEGF-A and Other Growth Factors with Potential Application in Wound Healing. ACS Chem Biol 13:91-99
Cai, Weijing; Matthew, Susan; Chen, Qi-Yin et al. (2018) Discovery of new A- and B-type laxaphycins with synergistic anticancer activity. Bioorg Med Chem 26:2310-2319
Al-Awadhi, Fatma H; Salvador, Lilibeth A; Law, Brian K et al. (2017) Kempopeptin C, a Novel Marine-Derived Serine Protease Inhibitor Targeting Invasive Breast Cancer. Mar Drugs 15:
Al-Awadhi, Fatma H; Law, Brian K; Paul, Valerie J et al. (2017) Grassystatins D-F, Potent Aspartic Protease Inhibitors from Marine Cyanobacteria as Potential Antimetastatic Agents Targeting Invasive Breast Cancer. J Nat Prod 80:2969-2986
Agarwal, Vinayak; Blanton, Jessica M; Podell, Sheila et al. (2017) Metagenomic discovery of polybrominated diphenyl ether biosynthesis by marine sponges. Nat Chem Biol 13:537-543
Paciaroni, Nicholas G; Ratnayake, Ranjala; Matthews, James H et al. (2017) A Tryptoline Ring-Distortion Strategy Leads to Complex and Diverse Biologically Active Molecules from the Indole Alkaloid Yohimbine. Chemistry 23:4327-4335
Alfurhood, Jawaher A; Sun, Hao; Kabb, Christopher P et al. (2017) Poly(N-(2-Hydroxypropyl) Methacrylamide)-Valproic Acid Conjugates as Block Copolymer Nanocarriers. Polym Chem 8:4983-4987
Kim, Bumki; Ratnayake, Ranjala; Lee, Hyunji et al. (2017) Synthesis and biological evaluation of largazole zinc-binding group analogs. Bioorg Med Chem 25:3077-3086
Meyer, Julie L; Gunasekera, Sarath P; Scott, Raymond M et al. (2016) Microbiome shifts and the inhibition of quorum sensing by Black Band Disease cyanobacteria. ISME J 10:1204-16

Showing the most recent 10 out of 26 publications